ELDN insider transaction filings
Eledon Pharmaceuticals, Inc. — 8 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-04. Screen ELDN transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-04 | 4 | Perrin Steven — President, Director | Grant/award (A): 152,353 @ $0 · Tax withholding (F): 72,138 @ $3.38 | EDGAR |
| 2026-08-04 | 4 | Gros David-Alexandre C — Chief Executive Officer, Director | Grant/award (A): 354,454 @ $0 · Tax withholding (F): 194,791 @ $3.38 | EDGAR |
| 2026-01-16 | 4 | McBride John S. — Director | Option exercise (M): 3,430 @ $0 · Option exercise (M): 3,430 (derivative) @ $0 | EDGAR |
| 2026-01-16 | 4 | Hillson Jan — Director | Option exercise (M): 3,430 @ $0 · Option exercise (M): 3,430 (derivative) @ $0 | EDGAR |
| 2026-01-16 | 4 | Kirk Allan — Director | Option exercise (M): 3,430 @ $0 · Option exercise (M): 3,430 (derivative) @ $0 | EDGAR |
| 2026-01-16 | 4 | Lee June — Director | Option exercise (M): 3,430 @ $0 · Option exercise (M): 3,430 (derivative) @ $0 | EDGAR |
| 2026-01-16 | 4 | Robinson James A. Jr. — Director | Option exercise (M): 3,430 @ $0 · Option exercise (M): 3,430 (derivative) @ $0 | EDGAR |
| 2026-01-16 | 4 | Katkin Keith — Director | Option exercise (M): 8,575 @ $0 · Option exercise (M): 8,575 (derivative) @ $0 | EDGAR |
Recent 8-K events — Eledon Pharmaceuticals, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-22 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-19 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-02 | 8-K | 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-07 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 4.02 — Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-06 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ELDN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →